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AbstrAct
Background Patients with cardiac pacemakers 
and defibrillators are disadvantaged because of poor 
access to MRI scans, leading to late and misdiagnosis 
particularly for cancer and neurological disease. New 
technology allied to tested protocols now allows safe 
MRI scanning of such patients; however, logistical 
barriers persist.
Aim To deliver a streamlined sustainable service that 
provides timely MRI scans to patients with cardiac 
implantable electronic devices (CIEDs).
Methods Patients requested a ’one-stop’ service for 
MRI, whereby devices could be reprogrammed and 
scans acquired at a single location and visit. To provide 
this ’one-stop’ service, we trained a team including 
administrators, physicians, cardiac physiologists and 
radiographers. A standard protocol was used to prevent 
unnecessary request refusals and delays to scheduling. 
Service volume, waiting time and safety were analysed 
6 months before and 2 years after service redesign. 
Waiting times for internal and external inpatient referrals 
plus time to treatment for patients on a cancer pathway 
were analysed.
Results 215 MRI scans were performed over 2 years. 
After service redesign, MRI provision increased six-fold to 
20 times the national average with reduced waiting time 
from 60 to 15 days and no adverse events. Departmental 
throughput was maintained. 85 (40%) referrals were 
external. 41 (19%) inpatients were scanned, reducing 
bed-stay by 3 days for internal referrals. 24 (11%) scans 
were for suspected cancer, 83% allowed treatment 
within the national standard of 62 days. There was no 
preintervention service for either inpatients or suspected 
cancer investigation.
Conclusion Implementation of a ’one-stop’ service 
model to provide MRI for patients with CIEDs is safe, 
streamlined, scalable and has reduced delays making 
economic and clinical sense. Protocols and checklists are 
available at  mrimypacemaker. com.
IntroductIon
Nearly half a million people in the UK have 
cardiac pacemaker or defibrillators,1 each 
with a 75% lifetime chance of needing 
a MRI scan.2 Clinicians are increasingly 
dependent on MRI for diagnosis and 
management of many acute, severe condi-
tions (cancer, stroke, radiotherapy plan-
ning, spinal cord compression), and it is 
the fastest growing imaging modality in 
the UK.3 Patients with cardiac pacemakers 
or defibrillators (collectively termed 
cardiac implantable electronic devices, 
CIEDs) are likely to benefit the most 
because they are older (one in 50 people 
over 65 have a pacemaker) and have 
more comorbities.4 Unfortunately, they 
have been prevented from having MRI 
scans due to historical safety concerns, 
resulting in more invasive, inaccurate 
testing and delayed treatment. There is 
now a large evidence base showing these 
scans can be performed safely following 
appropriate protocols.5 Manufacturers 
have also made software and hardware 
modifications to develop ‘MRI-condi-
tional’ CIEDs designed to undergo MRI. 
This makes scanning technically straight-
forward, but despite annual UK invest-
ment of over £100 million in MRI-condi-
tional CIEDs, patients still cannot access 
MRI scans because services are logistically 
difficult to provide.6–8
At our centre, we witnessed first-hand 
the clinical need and consequences of 
underprovision. We therefore addressed 
logistical barriers and aimed to deliver 
a streamlined sustainable service that 




MRI scanning for patients with CIEDs 
requires some additional steps to be taken 
both prior to imaging and on attendance. 
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Figure 1 Service redesign into a ‘one-stop’ service. ACLS, advanced cardiac life support.
After a referral is made, it is necessary to confirm 
whether the CIED is MRI-conditional. This can be 
done via patient records, device identification cards 
held by the patient or referrers. Logistics are similar if 
there is a non MRI-conditional CIED, but a clear indi-
cation is established in advance through a risk-benefit 
discussion.
Device checks must also take place before and imme-
diately after the MRI scan to check device integrity 
and to programme into MRI-mode. This is done either 
by a cardiac physiologist or cardiologist and requires 
a portable device programming unit. There is also a 
safety checklist to ensure that there are no exclusions 
to scanning (eg, recent device implantation).
During the scan, the patient is monitored using at 
least one of ECG or pulse-oximetry, and an external 
defibrillator with pacing capability should be available 
within the department. Scanning is performed using 
lower specific absorption rate power following manu-
facturer recommendations. On MRI completion, the 
device is restored to the initial settings after interro-
gation—either in the cardiology department or near 
the scanner.
Logistical barriers
Prior to redesigning our service, we surveyed all hospi-
tals in England performing MRI to understand obsta-
cles to service establishment, with an 86% response 
rate.7 Although 98% were aware of MRI-conditional 
devices, less than half provided scans to device patients, 
with only three performing more than 20 scans annu-
ally. Reported barriers to provision were primarily 
logistical and educational. There is limited cardiology 
and radiology interaction at physician and techni-
cian level, and so centralising a service that requires 
different parts of the hospital to work together is 
difficult. Because of a lack of training, clinicians also 
reported high perceived risk and safety concerns.
Local context
Two adjacent 1.5T MRI scanners within the cardiac 
imaging department were used for this project (in 
addition to a 3T scanner not used for patients with 
CIEDs). In total, the department performs more than 
7500 scans annually. This is within a large teaching 
hospital providing specialist tertiary referral cardiology 
and oncology services, which is paired with three large 
general hospitals. A full range of both cardiology and 
radiology services are available on-site. Prior to inter-
vention, scans for patients with CIEDs were scanned 
with ad-hoc liaison between cardiology and radiology 
services.
Locally, we surveyed patient experience and referral 
time. Of 15 patients with CIEDs surveyed after receiving 
an MRI appointment, 7 (47%) reported being denied 
an MRI scan at their local hospital because they had a 
pacemaker (even though MRI-conditional). 11 (73%) 
reported delays in receiving appointments; including 
two with waits of over 2.5 years.
setting and intervention
Patients and referrers requested a ‘one-stop’ service 
for MRI, whereby devices could be reprogrammed 
and scans acquired at a single location on a single 
visit. To provide a streamlined service (figure 1), we 
trained a team of named individuals including admin-
istrators, physicians, cardiac physiologists and radiog-
raphers and developed a standard booking protocol. 
This was designed to prevent unnecessary request 
refusals, prevent delays both to scheduling and during 
scanning and so improve efficiency, patient experi-
ence and safety. Because the team usually works in 
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Figure 2 Quarterly rates of MRI provision and waiting time for patients with cardiac implantable electronic devices before and after new pathway 
introduction. Waiting time defined as time from receipt of referral to scan date. National average quarterly scan provision from Sabzevari et al.7
different areas of the hospital, we organised bookings 
into preallocated scanning sessions for patients with 
CIEDs. These changes allowed all necessary staff to 
be present for the scan, and meant specific individuals 
could be trained to perform the service. No additional 
equipment or other fixed costs were needed.
With time, the model also gained economies of 
scale: radiographers felt confident to scan patients 
with MRI-conditional CIEDs without cardiologist 
supervision in the control room, and pathways were 
developed for streamlining external referrals and more 
complex non MRI-conditional devices. As the project 
developed, we adjusted pathways to improve patient 
experience—feedback from a paraplegic patient, for 
example, drove changes in the logistics of difficult 
interhospital transfers.
Measures of improvement
The primary outcomes were the volume of service 
provision; waiting time (receipt of referral to scan 
date) and safety as defined in the Magnasafe registry.9 
These were measured at quarterly intervals 6 months 
before and 2 years after service redesign in January 
2016. Inpatients and patients with a suspected cancer 
diagnosis were felt to be important groups.6 9 As there 
was minimal service provision before intervention, 
there were no baseline metrics of quality improvement 
for comparison. We therefore assessed whether scan 
results expedited inpatient flow by allowing discharge 
or determining procedural intervention. We also 
measured waiting time (clinical decision to scan date) 
for internal compared with external referrals. For 
patients with a suspected cancer diagnosis, we meas-
ured whether patients received treatment within the 
national standard of 62 days.10 Data were abstracted 
from hospital electronic medical informatics database 
including patient demographics, referral source, indi-
cation and follow-up management.
ethical considerations
According to the policy activities that constitute 
research locally, this work met criteria for operational 
improvement activities exempt from ethics review. 
The reporting of this quality improvement project was 
approved by the Institutional Quality Improvement 
Review Board and follows the proposed Standards 
for Quality Improvement Reporting Excellence guide-
lines.11
resuLts
service volume and waiting time
Total 215 MRI scans were performed over 24 months 
for patients with CIEDs (age 61±20 years, 67% male, 
19% hospitalised inpatients). In the 6 months prior 
to intervention, 6 scans/quarter were performed, 
increasing sixfold to 36 scans/quarter for the final 6 
months. This is 20 times the national average, figure 2. 
Waiting time also reduced from 60 (IQR: 34–71) to 15 
(IQR: 4–45) days. All MRI scans were performed safely 
with no adverse events, despite scanning patients with 
increasingly complex cardiac devices. All scans were 
performed for standard clinical indications often with 
no alternative imaging modalities. Given essentially 
absent service prior to the new model, all benefits are 
not merely incremental as patients would have had no 
access to standard NHS care. There was no reduction 
in total department activity.
Inpatients and cancer investigation
Forty-one (19%) inpatients were scanned, and 32% 
were for urgent diagnoses (cancer, stroke, cord 
compression or life-threatening heart rhythms). 
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Table 1 Waiting time in days for internal and external referrers
n Internal External Total
Overall 215 28 (7–60) 69 (16–107) 41 (8–79)
Inpatient 41 4 (1–10) 7 (1–17) 4 (1–13)
Outpatient 174 42 (16–116) 75 (39–66) 49 (22–80)
Data are represented as median (IQR). Waiting time defined as time 
from clinical decision to scan date.
Figure 3 Catchment of external referrals to the newly established service.
Eighty-three per cent expedited patient flow (discharge 
or determining procedural intervention) and scans 
were three bed-days faster for internal than external 
referrals, table 1. Twenty-four (11%) scans were for 
a suspected cancer diagnosis, with an 8 (IQR: 0–32) 
day waiting time. Eighty-three per cent allowed treat-
ment within the national standard of 62 days. There 
was no preintervention service for either inpatients or 
suspected cancer investigation.
referral location
Eighty-five (40%) referrals were from other hospitals 
and the service developed into a supraregional hub at 
an early stage (figure 3). Time from clinical decision 
to scan was 69 (IQR: 16–107) days for external refer-
rals compared with 28 (IQR: 7–60) days for internal 
referrals.
dIscussIon
We redesigned MRI provision for patients with CIEDs 
into a ‘one-stop’ service where devices could be repro-
grammed and scans acquired at a single location on a 
single visit. International guidelines, MRI-conditional 
pacemakers and two large studies last year alone have 
highlighted this important but difficult issue.5 9 12 
Based on our baseline data collection, we have shown 
that national provision is extremely low because of 
multiple barriers.7 There is lack of awareness among 
radiologists, cardiologists and referrers; logistical and 
funding barriers.7 8 In this context, we redesigned a 
service starting with a provision rate just above the 
national average and then became the largest UK 
centre and a supraregional hub.
By making scans easier to access, referrals increased 
six-fold but a streamlined model meant that the depart-
ment was able to perform scans safely, more efficiently 
and at scale. After 2 years, scan volume was over 20 
times the national average with a lower waiting time, 
and while maintaining total departmental activity. 
Before service redesign, patients with CIEDs could not 
access MRI, with delays in diagnosis of up to two and 
a half years. All benefits to patients were therefore not 
just incremental: making MRI available meant that 
patients were able to access standard NHS pathways. 
This was often for important indications such as diag-
nosis of stroke or spinal cord compression. One in 10 
scans were for cancer and these patients frequently 
reattended (up to seven occasions) to guide surgical 
resection, enable radiotherapy or confirm remission.
breaking down silos of practice
This was achieved by creating change with evidence-
based pathway redesign, introducing cultural change 
and new ways of working across silos of hospital prac-
tice. The need for new working practices to provide 
this service are recognised by the Royal College of 
Radiologists, British Cardiovascular Society and British 
Heart Rhythm Society guidelines.13 14 We specifically 
sought to understand and address barriers to service 
provision. Staff did not feel confident performing 
scans due to lack of training and so we concentrated 
experience in specific individuals. Logistically, it was 
difficult to collate the information needed to protocol 
scans. Training of the bookings team using a specific 
proforma similar to international guidelines ensured all 
decisions were made beforehand and delay was mini-
mised at the scanner-side.5 By creating a transparent 
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process, the team was able to approve scans faster 
and more frequently, but it required a learning curve 
to implement the process efficiently as represented by 
waiting time data figure 2. This should allay concerns 
of other services in coping with the increased demand. 
After concentrating experience in a few individuals, 
we could adapt our service model so radiographers 
performed some scans without supervision and the 
team were able to scan patients with increasingly 
complex devices with a pressing clinical indication 
safely (eg, CyberKnife planning). Radiographers were 
also able to ask for scan review for completeness by an 
appropriate imaging expert to avoid recall.
organisational benefits outweigh costs
Performing MRI scans for patients with CIED is in the 
best interests of the patient and the healthcare system. 
The diagnostic yield and clinical benefit from these 
scans is high—common requests are for suspected 
cord compression, stroke and cancer or planning for 
radiotherapy or neurosurgery. This is in agreement to 
other centres in the USA and Italy.6 8 Early diagnosis 
makes clinical and economic sense;15 the financial cost 
alone of a late cancer diagnosis is £4000 even when 
accounting for treatment costs, and an extra bed day is 
£222.16 17 This saving was most obvious for inpatients 
where bed stay reduced by 3 days for internal referrals. 
In the short term, prompt decision making meant early 
patient discharge (£17 300 saving on internal refer-
rals alone) and alternative suboptimal investigations 
avoided. This underestimates the benefit because this 
was compared with external referrals who also would 
not have had access to MRI prior to service redesign. 
In the medium to long term, health savings accrue 
with downstream cost savings of reduced population 
morbidity and associated social care.
The changes involved were primarily organisational 
and logistical, incorporating better interdisciplinary 
communication. Modest funding for device checks 
and staff time on the scan day was needed. MRI-con-
ditional devices are now standard of care in the UK, 
meaning the additional cost is already invested at 
device implantation. Eighty-five per cent of depart-
ments nationally currently have the necessary equip-
ment available.7
A growing clinical need
We were surprised at the frequency of external refer-
rals from across the UK for patients unable to access 
scans locally. The organic growth of our service into a 
supraregional hub even without advertising highlights 
the clinical urgency to develop this nationally. While 
unique, the knowledge and skills to provide this model 
elsewhere are scalable and may offer a template which 
does not significantly impact on resources. We also 
hope such a model can be used for other multidiscipli-
nary services necessary to deliver increasingly complex 
patient care.
A broader network approach, however, is needed to 
address this nationally. Ninety-four per cent of all MRI 
departments have cardiology on site and therefore 
could offer similar provision.7 Once a clinical decision 
had been made, it took externally referred patients 
41 days longer to receive a scan. This was because 
patients generally were booked for and refused scans 
locally, before our unit was approached. Information 
related to patients’ devices was also often not available 
to us, leading to delays in collating the necessary infor-
mation. To encourage other centres, direct contacts 
for scanning centres, national training courses, safety 
checklists and standard operating procedures are freely 
available online at  mrimypacemaker. com.
Limitations
Comparisons were made between internal and external 
referrals because of limited service prior to interven-
tion and so improvements are likely to be underesti-
mated. We have found that other local champions have 
faced their own barriers to service development which 
will depend on the individual microenvironment. It 
requires time to prepare for each scan which requires 
adequate administration resources and funding. The 
benefits observed are likely to be a combination both 
of service reorganisation with the ‘one-stop’ pathway, 
but also better awareness among referring clinicians 
and service providers. The relative contributions of 
these two factors are not known. Our service require-
ments continue to rise and this presents new chal-
lenges. Creating a network of scanning centres and 
establishing national tariffs that acknowledge the 
complexity will help to address this.
concLusIon
A service model for MRI provision to pacemaker and 
cardiac defibrillator patients is sustainable at scale. 
This is achieved by creating a protocol to reduce 
scheduling delays and a ‘one-stop’ visit for patients 
with the multidisciplinary team. Rapid service growth 
highlights the pressing clinical and economic bene-
fits of making MRI more available to cardiac device 
patients. Template standard operating procedures and 
checklists are available at  mrimypacemaker. com
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